DIA
VRTX icon

Dana Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Dana Investment Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,507
Closed -$1.12M – 579
2025
Q2 		$1.12M Sell
2,507
-142
-5% -$65.4K 0.04% 371
2025
Q1 		$1.28M Buy
2,649
+682
+35% +$318K 0.05% 343
2024
Q4 		$792K Sell
1,967
-21
-1% -$9.73K 0.03% 416
2024
Q3 		$925K Buy
1,988
+51
+3% +$24.5K 0.03% 392
2024
Q2 		$908K Sell
1,937
-268
-12% -$116K 0.03% 386
2024
Q1 		$922K Hold
2,205
– – 0.03% 378
2023
Q4 		$897K Buy
+2,205
New +$815K 0.04% 263
2021
Q1 		– Sell
-8,149
Closed -$1.93M – 341
2020
Q4 		$1.93M Sell
8,149
-3,792
-32% -$870K 0.1% 140
2020
Q3 		$3.25M Sell
11,941
-17,886
-60% -$4.93M 0.18% 94
2020
Q2 		$8.66M Buy
29,827
+15,114
+103% +$4.1M 0.47% 71
2020
Q1 		$3.5M Buy
14,713
+1,445
+11% +$331K 0.21% 78
2019
Q4 		$2.9M Sell
13,268
-991
-7% -$201K 0.14% 98
2019
Q3 		$2.42M Buy
14,259
+3,175
+29% +$562K 0.12% 109
2019
Q2 		$2.03M Sell
11,084
-6,487
-37% -$1.13M 0.1% 148
2019
Q1 		$3.23M Sell
17,571
-4,886
-22% -$902K 0.15% 101
2018
Q4 		$3.72M Sell
22,457
-2,476
-10% -$429K 0.19% 99
2018
Q3 		$4.81M Buy
+24,933
New +$4.44M 0.2% 97

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dana Investment Advisors's VRTX Position: Q3 2025 in Review

Dana Investment Advisors sold out of Vertex Pharmaceuticals (VRTX) in Q3 2025, closing a stake of 2,507 shares — an estimated $1.12M sold.

Dana Investment Advisors first reported a position in VRTX in Q3 2018 and held it in 17 quarters. The position peaked at $8.66M in Q2 2020. 1,519 funds tracked by Wall St. Rank hold VRTX as of Q3 2025.

  • Dana Investment Advisors reported no remaining Vertex Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Dana Investment Advisors sold 2,507 Vertex Pharmaceuticals shares in Q3 2025, an estimated $1.12M.
  • Dana Investment Advisors first reported a position in Vertex Pharmaceuticals in Q3 2018 and held it in 17 quarters.
  • Dana Investment Advisors's Vertex Pharmaceuticals position peaked at $8.66M in Q2 2020.
  • 1,519 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2025.

Based on Dana Investment Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.